The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Karpova M.I.
State educational institution of higher professional education «South Ural State Medical University», Russian Ministry of Health
Zariada A.A.
South Ural State Medical University, Russian Ministry of Health, Chelyabinsk
Dolgushina V.F.
Kafedra akusherstva i ginekologii
Korotkova D.G.
South Ural State Medical University, Russian Ministry of Health, Chelyabinsk
Ekusheva E.V.
Otdel patologii vegetativnoĭ nervnoĭ sistemy Nauchno-issledovatel'skogo tsentra Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, Moskva
Osipova V.V.
Research Department of Neurology, Scientific Research Center, I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
Moscow Research Clinical Centre for Neuropsychiatry, Moscow Health Department, Moscow, Russia
Migraine in women: clinical and therapeutical aspects
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(3): 98‑107
Views: 11045
Downloaded: 210
To cite this article:
Karpova MI, Zariada AA, Dolgushina VF, Korotkova DG, Ekusheva EV, Osipova VV. Migraine in women: clinical and therapeutical aspects. S.S. Korsakov Journal of Neurology and Psychiatry.
2019;119(3):98‑107. (In Russ.)
https://doi.org/10.17116/jnevro201911903198
Migraine is one of the most common neurological disorders, affecting women. Physiological changes in the hormonal status can modulate the functional status of pain and analgesic systems of the brain and, by involving different pathophysiological mechanisms, change the course of migraine. In addition to an analysis of epidemiological data, the review provides current views on the clinical features of the disease in women population at different periods of life, particular attention was focused on menstrual migraine. It has certain features, such as acute and long attacks and treatment difficulties. One of main issues is the use of oral contraceptives in women with migraine according to the ratio of potential benefit to cardiovascular risk. The problems of treatment headaches in pregnant and breastfeeding women are also considered. An influence of migraine on the course and outcome of pregnancy was shown. The authors analysed the results of the studies on the course of migraine during perimenopause and postmenopause and recommendations for women with migraine attacks and climacteric syndrome. The data presented in the review are useful for clinicians, because this information represents new views on pathogenetic mechanisms, clinical features and treatment of migraine in women.
Keywords:
Authors:
Karpova M.I.
State educational institution of higher professional education «South Ural State Medical University», Russian Ministry of Health
Zariada A.A.
South Ural State Medical University, Russian Ministry of Health, Chelyabinsk
Dolgushina V.F.
Kafedra akusherstva i ginekologii
Korotkova D.G.
South Ural State Medical University, Russian Ministry of Health, Chelyabinsk
Ekusheva E.V.
Otdel patologii vegetativnoĭ nervnoĭ sistemy Nauchno-issledovatel'skogo tsentra Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, Moskva
Osipova V.V.
Research Department of Neurology, Scientific Research Center, I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
Moscow Research Clinical Centre for Neuropsychiatry, Moscow Health Department, Moscow, Russia
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.